Bax-interacting factor-1 expression in prostate cancer

Clinical Genitourinary Cancer

Volumn 6, Issue 2, 2008, Pages 117-121

  Coppola, Domenico ^a   Oliveri, Cecilia ^a   Sayegh, Zena ^a   Boulware, David ^a   Takahashi, Yoshinori ^a   Pow Sang, Julio ^a   Djeu, Julie Y ^a   Wang, Hong Gang ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Benign prostatic hyperplasia; Immunohistochemistry; Prostatic intraepithelial neoplasia; Tissue microarray

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; BAX INTERACTING FACTOR 1 ANTIBODY; BAX INTERACTING FACTOR 1 PROTEIN; HORMONE; PROTEIN; UNCLASSIFIED DRUG; SH3GLB1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER THERAPY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SAMPLE; SCORING SYSTEM; STAINING; TISSUE MICROARRAY; ADENOCARCINOMA; ANTIBODY SPECIFICITY; METABOLISM; MIDDLE AGED; PROSTATE TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 58149190801     PISSN: 15587673     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2008.n.018     Document Type: Article

References (27)

1. (Pubitemid 38661087) McDavid K, Lee J, Fulton JP, et al. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004; 119: 174-86.
2. Bono AV. The global state of prostate cancer: epidemiology and screening in the second millennium. BJU Int 2004; 94 (suppl 3) : 1-2.
3. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17: 64-71.
4. Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol 1999; 17: 187-98.
5. (Pubitemid 44402203) Humphrey PA. Prostatic intraepithelial neoplasia. Prostate Pathology. Chicago, IL: ASCP Press; 2003:183-217.
6. Quinn BD, Cho KR, Epstein JI. Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 1990; 65: 2328-37.
7. Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994; 8: 439-43.
8. Chao OS, Clement MV. Epidermal growth factor and serum activate distinct pathways to inhibit the BH3 only protein BAD in prostate carcinoma LNCaP cells. Oncogene 2006; 25: 4458-69.
9. Castilla C, Congregado B, Chinchon D, et al. Bcl-xL is overexpressed in hormoneresistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 2006; 147: 4960-7.
10. (Pubitemid 43989441) Iacopino F, Angelucci C, Lama G, et al. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Anticancer Res 2006; 26: 1849-54.
11. (Pubitemid 41507838) Takahashi Y, Karbowski M, Yamaguchi H, et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol 2005; 25: 9369-82.
12. Lee JW, Jeong EG, Soung YH, et al. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006; 38: 312-5.
13. (Pubitemid 37411141) Cuddeback SM, Yamaguchi H, Komatsu K, et al. Molecular cloning and characterization of Bif-1: a novel SH3 domain-containing protein that associates with Bax. J Biol Chem 2001; 276: 20559-65.
14. (Pubitemid 32165089) Pierrat B, Simonen M, Cueto M, et al. SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics 2001; 71: 222-34.
15. (Pubitemid 34106420) Yamaguchi H, Paranawithana SR, Lee MW, et al. Epothilone B analogue (BMS-247550) -mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res 2002; 62: 466-71.
16. (Pubitemid 47500490) Takahashi Y, Coppola D, Matsushita N, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007; 9: 1142-51.
17. Bonner AE, Lemon WJ, Devereux TR, et al. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 2004; 23: 1166-76.
18. (Pubitemid 44360176) Balakrishnan A, von Neuhoff N, Rudolph C, et al. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. Genes Chromosomes Cancer 2006; 45: 883-92.
19. (Pubitemid 38988738) Walker GJ, Indsto JO, Sood R, et al. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer 2004; 41: 56-64.
20. (Pubitemid 26330424) Lee WC, Balsara B, Liu Z, et al. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res 1996; 56: 4297-301.
21. (Pubitemid 128766336) Roberts T, Chernova O, Cowell JK. Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t (1;10) (p22;q21). Cancer Genet Cytogenet 1998; 100: 10-20.
22. (Pubitemid 32453330) Kakinuma H, Habuchi T, Ito T, et al. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors. Cancer Genet Cytogenet 2001; 126: 134-8.
23. (Pubitemid 30410774) Mora J, Cheung NK, Kushner BH, et al. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn 2000; 2: 37-46.
24. Emi M, Matsumoto S, Iida A, et al. Correlation of allelic losses and clinicopathological factors in primary breast cancers. Breast Cancer 1997; 4: 243-6.
25. Bello MJ, de Campos JM, Vaquero J, et al. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 2000; 120: 30-6.
26. (Pubitemid 34169857) Knosel T, Petersen S, Schwabe H, et al. Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch 2002; 440: 187-94.
27. (Pubitemid 38456176) Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-77.